Acrivon Therapeutics, Inc. (ACRV)

1.83 +0.13 (+7.65%) USD  |  NASDAQ  |  Jan 14, 16:00
1.84 +0.01 (+0.55%) After-Hours: 05:14
More

Acrivon Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ACRV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Aclarion, Inc. Upgrade
Vistagen Therapeutics, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Humacyte, Inc. --
PMGC Holdings, Inc. --